{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:44:06Z","timestamp":1795113846042,"version":"4.10.3"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073237"],"award-info":[{"award-number":["82073237"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473083"],"award-info":[{"award-number":["82473083"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515012487"],"award-info":[{"award-number":["2022A1515012487"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-025-05881-9","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:11:25Z","timestamp":1761653485000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["MPC-mediated lactate production drives histone lactylation in dendritic cells to affect tumor progression and immunotherapy"],"prefix":"10.1007","volume":"82","author":[{"given":"Bin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0811-0696","authenticated-orcid":false,"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"issue":"3191","key":"5881_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O (1956) On the origin of cancer cells. Science (New York, NY) 123(3191):309\u2013314","journal-title":"Science (New York, NY)"},{"issue":"2","key":"5881_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tibs.2018.10.011","volume":"44","author":"L Ippolito","year":"2019","unstructured":"Ippolito L, Morandi A, Giannoni E, Chiarugi P (2019) Lactate: a metabolic driver in the tumour landscape. Trends Biochem Sci 44(2):153\u2013166","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"5881_CR3","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.3390\/cancers12113244","volume":"12","author":"R P\u00e9rez-Tom\u00e1s","year":"2020","unstructured":"P\u00e9rez-Tom\u00e1s R, P\u00e9rez-Guill\u00e9n I (2020) lactate in the tumor microenvironment: an essential molecule in cancer progression and treatment. Cancers 12(11):3244","journal-title":"Cancers"},{"issue":"16","key":"5881_CR4","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1158\/0008-5472.CAN-19-0617","volume":"79","author":"VM Ngwa","year":"2019","unstructured":"Ngwa VM, Edwards DN, Philip M, Chen J (2019) Microenvironmental metabolism regulates antitumor immunity. Cancer Res 79(16):4003\u20134008","journal-title":"Cancer Res"},{"issue":"7851","key":"5881_CR5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson MJ, Vignali PDA, Mullett SJ, Overacre-Delgoffe AE, Peralta RM, Grebinoski S et al (2021) Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature 591(7851):645\u2013651","journal-title":"Nature"},{"issue":"6","key":"5881_CR6","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","volume":"25","author":"A Angelin","year":"2017","unstructured":"Angelin A, Gil-de-G\u00f3mez L, Dahiya S, Jiao J, Guo L, Levine MH et al (2017) Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab 25(6):1282\u201393.e7","journal-title":"Cell Metab"},{"issue":"5","key":"5881_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41423-019-0224-2","volume":"16","author":"G Habif","year":"2019","unstructured":"Habif G, Crinier A, Andr\u00e9 P, Vivier E, Narni-Mancinelli E (2019) Targeting natural killer cells in solid tumors. Cell Mol Immunol 16(5):415\u2013422","journal-title":"Cell Mol Immunol"},{"key":"5881_CR8","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.3389\/fimmu.2019.02278","volume":"10","author":"I Terr\u00e9n","year":"2019","unstructured":"Terr\u00e9n I, Orrantia A, Vitall\u00e9 J, Zenarruzabeitia O, Borrego F (2019) NK cell metabolism and tumor microenvironment. Front Immunol 10:2278","journal-title":"Front Immunol"},{"issue":"7519","key":"5881_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio OR, Chu NQ, Szabo AL, Chu T, Rhebergen AM, Jairam V et al (2014) Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513(7519):559\u2013563","journal-title":"Nature"},{"key":"5881_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3389\/fimmu.2017.00270","volume":"8","author":"S Kouidhi","year":"2017","unstructured":"Kouidhi S, Elgaaied AB, Chouaib S (2017) Impact of metabolism on T-cell differentiation and function and cross talk with tumor microenvironment. Front Immunol 8:270","journal-title":"Front Immunol"},{"issue":"1","key":"5881_CR11","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1038\/s41467-020-17756-7","volume":"11","author":"H Wu","year":"2020","unstructured":"Wu H, Estrella V, Beatty M, Abrahams D, El-Kenawi A, Russell S et al (2020) T-cells produce acidic niches in lymph nodes to suppress their own effector functions. Nat Commun 11(1):4113","journal-title":"Nat Commun"},{"issue":"1","key":"5881_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s42255-022-00710-w","volume":"5","author":"Z Yang","year":"2023","unstructured":"Yang Z, Yan C, Ma J, Peng P, Ren X, Cai S et al (2023) Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nat Metab 5(1):61\u201379","journal-title":"Nat Metab"},{"issue":"4","key":"5881_CR13","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s10753-022-01637-w","volume":"45","author":"Q Xin","year":"2022","unstructured":"Xin Q, Wang H, Li Q, Liu S, Qu K, Liu C et al (2022) Lactylation: a passing fad or the future of posttranslational modification. Inflammation 45(4):1419\u20131429","journal-title":"Inflammation"},{"key":"5881_CR14","doi-asserted-by":"publisher","first-page":"949252","DOI":"10.3389\/fgene.2022.949252","volume":"13","author":"Y Xie","year":"2022","unstructured":"Xie Y, Hu H, Liu M, Zhou T, Cheng X, Huang W et al (2022) The role and mechanism of histone lactylation in health and diseases. Front Genet 13:949252","journal-title":"Front Genet"},{"issue":"11","key":"5881_CR15","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/CIRCRESAHA.122.320488","volume":"131","author":"N Wang","year":"2022","unstructured":"Wang N, Wang W, Wang X, Mang G, Chen J, Yan X et al (2022) Histone lactylation boosts reparative gene activation post-myocardial infarction. Circ Res 131(11):893\u2013908","journal-title":"Circ Res"},{"key":"5881_CR16","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1017\/erm.2022.42","volume":"25","author":"X Lv","year":"2023","unstructured":"Lv X, Lv Y, Dai X (2023) Lactate, histone lactylation and cancer hallmarks. Expert Rev Mol Med 25:e7","journal-title":"Expert Rev Mol Med"},{"issue":"19","key":"5881_CR17","doi-asserted-by":"publisher","first-page":"11943","DOI":"10.3390\/ijms231911943","volume":"23","author":"L Chen","year":"2022","unstructured":"Chen L, Huang L, Gu Y, Cang W, Sun P, Xiang Y (2022) Lactate-lactylation hands between metabolic reprogramming and immunosuppression. Int J Mol Sci 23(19):11943","journal-title":"Int J Mol Sci"},{"issue":"6090","key":"5881_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1126\/science.1218099","volume":"337","author":"DK Bricker","year":"2012","unstructured":"Bricker DK, Taylor EB, Schell JC, Orsak T, Boutron A, Chen YC et al (2012) A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science 337(6090):96\u2013100","journal-title":"Science"},{"issue":"6090","key":"5881_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1126\/science.1218530","volume":"337","author":"S Herzig","year":"2012","unstructured":"Herzig S, Raemy E, Montessuit S, Veuthey JL, Zamboni N, Westermann B et al (2012) Identification and functional expression of the mitochondrial pyruvate carrier. Science 337(6090):93\u201396","journal-title":"Science"},{"issue":"13","key":"5881_CR20","doi-asserted-by":"publisher","first-page":"e126132","DOI":"10.1172\/jci.insight.126132","volume":"5","author":"L Oonthonpan","year":"2019","unstructured":"Oonthonpan L, Rauckhorst AJ, Gray LR, Boutron AC, Taylor EB (2019) Two human patient mitochondrial pyruvate carrier mutations reveal distinct molecular mechanisms of dysfunction. JCI Insight 5(13):e126132","journal-title":"JCI Insight"},{"key":"5881_CR21","doi-asserted-by":"publisher","first-page":"8340329","DOI":"10.1155\/2020\/8340329","volume":"2020","author":"GA Tian","year":"2020","unstructured":"Tian GA, Xu CJ, Zhou KX, Zhang ZG, Gu JR, Zhang XL et al (2020) MPC1 deficiency promotes CRC liver metastasis via facilitating nuclear translocation of beta-catenin. J Immunol Res 2020:8340329","journal-title":"J Immunol Res"},{"issue":"5","key":"5881_CR22","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s41388-019-1051-8","volume":"39","author":"J Cui","year":"2020","unstructured":"Cui J, Quan M, Xie D, Gao Y, Guha S, Fallon MB et al (2020) A novel KDM5A\/MPC-1 signaling pathway promotes pancreatic cancer progression via redirecting mitochondrial pyruvate metabolism. Oncogene 39(5):1140\u20131151","journal-title":"Oncogene"},{"issue":"3","key":"5881_CR23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.molcel.2014.09.026","volume":"56","author":"JC Schell","year":"2014","unstructured":"Schell JC, Olson KA, Jiang L, Hawkins AJ, Van Vranken JG, Xie J et al (2014) A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth. Mol Cell 56(3):400\u2013413","journal-title":"Mol Cell"},{"issue":"8","key":"5881_CR24","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.4049\/jimmunol.1901484","volume":"204","author":"HA Ekiz","year":"2020","unstructured":"Ekiz HA, Ramstead AG, Lee SH, Nelson MC, Bauer KM, Wallace JA et al (2020) T cell-expressed microrna-155 reduces lifespan in a mouse model of age-related chronic inflammation. J Immunol 204(8):2064\u20132075","journal-title":"J Immunol"},{"issue":"5","key":"5881_CR25","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cmet.2022.03.013","volume":"34","author":"M Wenes","year":"2022","unstructured":"Wenes M, Jaccard A, Wyss T, Maldonado-Perez N, Teoh ST, Lepez A et al (2022) The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function. Cell Metab 34(5):731\u201346 e9","journal-title":"Cell Metab"},{"issue":"1","key":"5881_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.immuni.2016.06.011","volume":"45","author":"WY Lam","year":"2016","unstructured":"Lam WY, Becker AM, Kennerly KM, Wong R, Curtis JD, Llufrio EM et al (2016) Mitochondrial pyruvate import promotes long-term survival of antibody-secreting plasma cells. Immunity 45(1):60\u201373","journal-title":"Immunity"},{"issue":"1","key":"5881_CR27","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/path.2575","volume":"219","author":"S Wang","year":"2009","unstructured":"Wang S, Zhou J, Wang XY, Hao JM, Chen JZ, Zhang XM et al (2009) Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer. J Pathol 219(1):114\u2013122","journal-title":"J Pathol"},{"issue":"11","key":"5881_CR28","doi-asserted-by":"publisher","first-page":"e2249816","DOI":"10.1002\/eji.202249816","volume":"53","author":"MB Lutz","year":"2023","unstructured":"Lutz MB, Ali S, Audiger C, Autenrieth SE, Berod L, Bigley V et al (2023) Guidelines for mouse and human DC generation. Eur J Immunol 53(11):e2249816","journal-title":"Eur J Immunol"},{"issue":"11","key":"5881_CR29","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","volume":"24","author":"TM Ashton","year":"2018","unstructured":"Ashton TM, McKenna WG, Kunz-Schughart LA, Higgins GS (2018) Oxidative phosphorylation as an emerging target in cancer therapy. Clin Cancer Res 24(11):2482\u20132490","journal-title":"Clin Cancer Res"},{"issue":"5930","key":"5881_CR30","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930):1029\u20131033","journal-title":"Science"},{"issue":"W1","key":"5881_CR31","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q et al (2020) TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res 48(W1):W509-w14","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"5881_CR32","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS et al (2017) TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res 77(21):e108\u2013e110","journal-title":"Cancer Res"},{"issue":"1","key":"5881_CR33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","volume":"17","author":"B Li","year":"2016","unstructured":"Li B, Severson E, Pignon JC, Zhao H, Li T, Novak J et al (2016) Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol 17(1):174","journal-title":"Genome Biol"},{"issue":"1\u20132","key":"5881_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.imbio.2004.04.007","volume":"209","author":"K Lock","year":"2004","unstructured":"Lock K, Zhang J, Lu J, Lee SH, Crocker PR (2004) Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells. Immunobiology 209(1\u20132):199\u2013207","journal-title":"Immunobiology"},{"issue":"7779","key":"5881_CR35","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y et al (2019) Metabolic regulation of gene expression by histone lactylation. Nature 574(7779):575\u2013580","journal-title":"Nature"},{"issue":"15","key":"5881_CR36","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1016\/j.cell.2024.06.026","volume":"187","author":"SM Fendt","year":"2024","unstructured":"Fendt SM (2024) 100 years of the Warburg effect: a cancer metabolism endeavor. Cell 187(15):3824\u20133828","journal-title":"Cell"},{"issue":"14","key":"5881_CR37","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1007\/s00018-013-1539-2","volume":"71","author":"LR Gray","year":"2014","unstructured":"Gray LR, Tompkins SC, Taylor EB (2014) Regulation of pyruvate metabolism and human disease. Cell Mol Life Sci 71(14):2577\u20132604","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"5881_CR38","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3390\/cancers13071488","volume":"13","author":"A Ruiz-Iglesias","year":"2021","unstructured":"Ruiz-Iglesias A, Ma\u00f1es S (2021) The importance of mitochondrial pyruvate carrier in cancer cell metabolism and tumorigenesis. Cancers 13(7):1488","journal-title":"Cancers"},{"key":"5881_CR39","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","volume":"31","author":"M Merad","year":"2013","unstructured":"Merad M, Sathe P, Helft J, Miller J, Mortha A (2013) The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 31:563\u2013604","journal-title":"Annu Rev Immunol"},{"issue":"70","key":"5881_CR40","doi-asserted-by":"publisher","first-page":"eabm9409","DOI":"10.1126\/sciimmunol.abm9409","volume":"7","author":"E Kvedaraite","year":"2022","unstructured":"Kvedaraite E, Ginhoux F (2022) Human dendritic cells in cancer. Sci Immunol 7(70):eabm9409","journal-title":"Sci Immunol"},{"issue":"1","key":"5881_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/imm.12888","volume":"154","author":"M Collin","year":"2018","unstructured":"Collin M, Bigley V (2018) Human dendritic cell subsets: an update. Immunology 154(1):3\u201320","journal-title":"Immunology"},{"issue":"6342","key":"5881_CR42","doi-asserted-by":"publisher","first-page":"eaag3009","DOI":"10.1126\/science.aag3009","volume":"356","author":"P See","year":"2017","unstructured":"See P, Dutertre CA, Chen J, G\u00fcnther P, McGovern N, Irac SE et al (2017) Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 356(6342):eaag3009","journal-title":"Science."},{"issue":"10","key":"5881_CR43","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3390\/cells8101125","volume":"8","author":"SS Siddiqui","year":"2019","unstructured":"Siddiqui SS, Matar R, Merheb M, Hodeify R, Vazhappilly CG, Marton J et al (2019) Siglecs in brain function and neurological disorders. Cells 8(10):1125","journal-title":"Cells"},{"issue":"1","key":"5881_CR44","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s12035-013-8536-1","volume":"49","author":"T Jiang","year":"2014","unstructured":"Jiang T, Yu JT, Hu N, Tan MS, Zhu XC, Tan L (2014) CD33 in Alzheimer\u2019s disease. Mol Neurobiol 49(1):529\u2013535","journal-title":"Mol Neurobiol"},{"issue":"4","key":"5881_CR45","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1159\/000492596","volume":"65","author":"L Zhao","year":"2019","unstructured":"Zhao L (2019) CD33 in Alzheimer\u2019s disease - biology, pathogenesis, and therapeutics: a mini-review. Gerontology 65(4):323\u2013331","journal-title":"Gerontology"},{"issue":"8","key":"5881_CR46","doi-asserted-by":"publisher","first-page":"e340","DOI":"10.1038\/bcj.2015.68","volume":"5","author":"GS Laszlo","year":"2015","unstructured":"Laszlo GS, Gudgeon CJ, Harrington KH, Walter RB (2015) T-cell ligands modulate the cytolytic activity of the CD33\/CD3 BiTE antibody construct, AMG 330. Blood Cancer J 5(8):e340","journal-title":"Blood Cancer J"},{"key":"5881_CR47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fimmu.2014.00024","volume":"5","author":"H Dong","year":"2014","unstructured":"Dong H, Bullock TN (2014) Metabolic influences that regulate dendritic cell function in tumors. Front Immunol 5:24","journal-title":"Front Immunol"},{"issue":"2","key":"5881_CR48","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41577-020-00413-x","volume":"21","author":"DA Anderson 3rd","year":"2021","unstructured":"Anderson DA 3rd, Dutertre CA, Ginhoux F, Murphy KM (2021) Genetic models of human and mouse dendritic cell development and function. Nat Rev Immunol 21(2):101\u2013115","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"5881_CR49","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41580-018-0081-3","volume":"20","author":"T Narita","year":"2019","unstructured":"Narita T, Weinert BT, Choudhary C (2019) Functions and mechanisms of non-histone protein acetylation. Nat Rev Mol Cell Biol 20(3):156\u2013174","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"5881_CR50","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1128\/MCB.23.8.2953-2968.2003","volume":"23","author":"V Hietakangas","year":"2003","unstructured":"Hietakangas V, Ahlskog JK, Jakobsson AM, Hellesuo M, Sahlberg NM, Holmberg CI et al (2003) Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1. Mol Cell Biol 23(8):2953\u20132968","journal-title":"Mol Cell Biol"},{"issue":"7","key":"5881_CR51","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1074\/jbc.M509471200","volume":"281","author":"S Gr\u00e9goire","year":"2006","unstructured":"Gr\u00e9goire S, Tremblay AM, Xiao L, Yang Q, Ma K, Nie J et al (2006) Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation. J Biol Chem 281(7):4423\u20134433","journal-title":"J Biol Chem"},{"issue":"19","key":"5881_CR52","doi-asserted-by":"publisher","first-page":"8456","DOI":"10.1128\/MCB.25.19.8456-8464.2005","volume":"25","author":"X Zhao","year":"2005","unstructured":"Zhao X, Sternsdorf T, Bolger TA, Evans RM, Yao TP (2005) Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications. Mol Cell Biol 25(19):8456\u20138464","journal-title":"Mol Cell Biol"},{"issue":"7","key":"5881_CR53","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1128\/MCB.01098-06","volume":"27","author":"N Stankovic-Valentin","year":"2007","unstructured":"Stankovic-Valentin N, Deltour S, Seeler J, Pinte S, Vergoten G, Gu\u00e9rardel C et al (2007) An acetylation\/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity. Mol Cell Biol 27(7):2661\u20132675","journal-title":"Mol Cell Biol"},{"issue":"12","key":"5881_CR54","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","volume":"13","author":"L Sun","year":"2022","unstructured":"Sun L, Zhang H, Gao P (2022) Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein Cell 13(12):877\u2013919","journal-title":"Protein Cell"},{"issue":"7","key":"5881_CR55","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc2876","volume":"10","author":"P Chi","year":"2010","unstructured":"Chi P, Allis CD, Wang GG (2010) Covalent histone modifications\u2013miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer 10(7):457\u2013469","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"5881_CR56","first-page":"453","volume":"32","author":"S Sun","year":"2017","unstructured":"Sun S, Li H, Chen J, Qian Q (2017) Lactic acid: no longer an inert and end-product of glycolysis. Physiology (Bethesda) 32(6):453\u2013463","journal-title":"Physiology (Bethesda)"},{"issue":"12","key":"5881_CR57","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41576-020-0270-8","volume":"21","author":"Z Dai","year":"2020","unstructured":"Dai Z, Ramesh V, Locasale JW (2020) The evolving metabolic landscape of chromatin biology and epigenetics. Nat Rev Genet 21(12):737\u2013753","journal-title":"Nat Rev Genet"},{"issue":"3","key":"5881_CR58","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s13402-023-00775-z","volume":"46","author":"JH Wang","year":"2023","unstructured":"Wang JH, Mao L, Wang J, Zhang X, Wu M, Wen Q et al (2023) Beyond metabolic waste: lysine lactylation and its potential roles in cancer progression and cell fate determination. Cell Oncol 46(3):465\u2013480","journal-title":"Cell Oncol"},{"key":"5881_CR59","doi-asserted-by":"publisher","first-page":"688910","DOI":"10.3389\/fimmu.2021.688910","volume":"12","author":"AN Chen","year":"2021","unstructured":"Chen AN, Luo Y, Yang YH, Fu JT, Geng XM, Shi JP et al (2021) Lactylation, a novel metabolic reprogramming code: current status and prospects. Front Immunol 12:688910","journal-title":"Front Immunol"},{"issue":"1","key":"5881_CR60","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41423-021-00727-3","volume":"19","author":"BI Reinfeld","year":"2022","unstructured":"Reinfeld BI, Rathmell WK, Kim TK, Rathmell JC (2022) The therapeutic implications of immunosuppressive tumor aerobic glycolysis. Cell Mol Immunol 19(1):46\u201358","journal-title":"Cell Mol Immunol"},{"issue":"9","key":"5881_CR61","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LA O'Neill","year":"2016","unstructured":"O\u2019Neill LA, Kishton RJ, Rathmell J (2016) A guide to immunometabolism for immunologists. Nat Rev Immunol 16(9):553\u2013565","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"5881_CR62","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1038\/s41467-020-17670-y","volume":"11","author":"C Robert","year":"2020","unstructured":"Robert C (2020) A decade of immune-checkpoint inhibitors in cancer therapy. Nat Commun 11(1):3801","journal-title":"Nat Commun"},{"key":"5881_CR63","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","volume":"16","author":"S Bagchi","year":"2021","unstructured":"Bagchi S, Yuan R, Engleman EG (2021) Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance. Annu Rev Pathol Mech Dis 16:223\u2013249","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"1","key":"5881_CR64","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13045-021-01056-8","volume":"14","author":"JA Marin-Acevedo","year":"2021","unstructured":"Marin-Acevedo JA, Kimbrough EO, Lou Y (2021) Next generation of immune checkpoint inhibitors and beyond. J Hematol Oncol 14(1):45","journal-title":"J Hematol Oncol"},{"issue":"2","key":"5881_CR65","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1208\/s12248-021-00574-0","volume":"23","author":"JD Twomey","year":"2021","unstructured":"Twomey JD, Zhang B (2021) Cancer immunotherapy update: FDA-approved checkpoint inhibitors and companion diagnostics. AAPS J 23(2):39","journal-title":"AAPS J"},{"issue":"1","key":"5881_CR66","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","volume":"21","author":"M Yi","year":"2022","unstructured":"Yi M, Zheng X, Niu M, Zhu S, Ge H, Wu K (2022) Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions. Mol Cancer 21(1):28","journal-title":"Mol Cancer"},{"issue":"4","key":"5881_CR67","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1124\/pr.114.009456","volume":"67","author":"S Anguille","year":"2015","unstructured":"Anguille S, Smits EL, Bryant C, Van Acker HH, Goossens H, Lion E et al (2015) Dendritic cells as pharmacological tools for cancer immunotherapy. Pharmacol Rev 67(4):731\u2013753","journal-title":"Pharmacol Rev"},{"issue":"13","key":"5881_CR68","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1182\/blood-2001-11-0097","volume":"100","author":"KP MacDonald","year":"2002","unstructured":"MacDonald KP, Munster DJ, Clark GJ, Dzionek A, Schmitz J, Hart DN (2002) Characterization of human blood dendritic cell subsets. Blood 100(13):4512\u20134520","journal-title":"Blood"},{"issue":"1","key":"5881_CR69","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/hep.32348","volume":"77","author":"Y Fang","year":"2023","unstructured":"Fang Y, Liu W, Tang Z, Ji X, Zhou Y, Song S et al (2023) Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack. Hepatology 77(1):109\u2013123","journal-title":"Hepatology"},{"issue":"1","key":"5881_CR70","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.celrep.2019.08.068","volume":"29","author":"K Renner","year":"2019","unstructured":"Renner K, Bruss C, Schnell A, Koehl G, Becker HM, Fante M et al (2019) Restricting glycolysis preserves T cell effector functions and augments checkpoint therapy. Cell Rep 29(1):135\u201350 e9","journal-title":"Cell Rep"},{"issue":"6","key":"5881_CR71","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ccell.2019.05.004","volume":"35","author":"D Dangaj","year":"2019","unstructured":"Dangaj D, Bruand M, Grimm AJ, Ronet C, Barras D, Duttagupta PA et al (2019) Cooperation between constitutive and inducible chemokines enables T cell engraftment and immune attack in solid tumors. Cancer Cell 35(6):885-900.e10","journal-title":"Cancer Cell"},{"issue":"1","key":"5881_CR72","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12935-024-03520-0","volume":"24","author":"F Cappellesso","year":"2024","unstructured":"Cappellesso F, Mazzone M, Virga F (2024) Acid affairs in anti-tumour immunity. Cancer Cell Int 24(1):354","journal-title":"Cancer Cell Int"},{"issue":"10","key":"5881_CR73","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrc.2017.77","volume":"17","author":"C Corbet","year":"2017","unstructured":"Corbet C, Feron O (2017) Tumour acidosis: from the passenger to the driver\u2019s seat. Nat Rev Cancer 17(10):577\u2013593","journal-title":"Nat Rev Cancer"},{"key":"5881_CR74","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-physiol-021119-034627","volume":"82","author":"E Boedtkjer","year":"2020","unstructured":"Boedtkjer E, Pedersen SF (2020) The acidic tumor microenvironment as a driver of cancer. Annu Rev Physiol 82:103\u2013126","journal-title":"Annu Rev Physiol"},{"issue":"5","key":"5881_CR75","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand A, Singer K, Koehl GE, Kolitzus M, Schoenhammer G, Thiel A et al (2016) LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab 24(5):657\u2013671","journal-title":"Cell Metab"},{"issue":"8","key":"5881_CR76","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.cmet.2022.06.008","volume":"34","author":"I Elia","year":"2022","unstructured":"Elia I, Rowe JH, Johnson S, Joshi S, Notarangelo G, Kurmi K et al (2022) Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8(+) T cells. Cell Metab 34(8):1137\u201350.e6","journal-title":"Cell Metab"},{"issue":"9","key":"5881_CR77","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","volume":"109","author":"K Fischer","year":"2007","unstructured":"Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M et al (2007) Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109(9):3812\u20133819","journal-title":"Blood"},{"issue":"1","key":"5881_CR78","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1038\/s41467-022-32521-8","volume":"13","author":"Q Feng","year":"2022","unstructured":"Feng Q, Liu Z, Yu X, Huang T, Chen J, Wang J et al (2022) Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity. Nat Commun 13(1):4981","journal-title":"Nat Commun"},{"issue":"1\u20132","key":"5881_CR79","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cytogfr.2007.01.002","volume":"18","author":"J Sabatt\u00e9","year":"2007","unstructured":"Sabatt\u00e9 J, Maggini J, Nahmod K, Amaral MM, Mart\u00ednez D, Salamone G et al (2007) Interplay of pathogens, cytokines and other stress signals in the regulation of dendritic cell function. Cytokine Growth Factor Rev 18(1\u20132):5\u201317","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"5881_CR80","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41392-021-00506-6","volume":"6","author":"Z Duan","year":"2021","unstructured":"Duan Z, Luo Y (2021) Targeting macrophages in cancer immunotherapy. Signal Transduct Target Ther 6(1):127","journal-title":"Signal Transduct Target Ther"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05881-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05881-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05881-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:06:28Z","timestamp":1761696388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05881-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5881"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05881-9","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The use of clinical tissue specimens for this study was approved by the ethics committee of Nanfang Hospital, Southern Medical University (Guangzhou, China; no. NFEC-2021\u2013108). All of the patients signed an informed consent form before their clinical materials were used for research purposes. The peripheral blood samples were collected from healthy researchers themselves and hepatitis B, tuberculosis, AIDS, tumor, fever, infectious diseases, or other diseases were excluded. Moreover, the animal experiments were performed in strict accordance with the recommendations in the NIH\n                      Guide for the Care and Use of Laboratory Animals\n                      (National Academies Press, 2011). The protocol was approved by the Animal Ethics Committee of Nanfang Hospital, Southern Medical University (no. NFYY-2019\u20131118).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants have written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"371"}}